World of DTC Marketing
JULY 27, 2022
A federal appeals court rejected Pfizer’s challenge to a U.S. anti-kickback law that the drugmaker said prevented it from helping heart failure patients, many with low incomes, afford the medicine that costs $225,000 annually. For many, these coupons represent the difference between filling a prescription and going without lifesaving care, but there is a lot more here than just a co-pay coupon.
Pharma Marketing Network
JULY 27, 2022
In the first two weeks after a cancer diagnosis, there are likely dozens of doctor’s visits, tests, consultations, and decision points. The patient care team supplies an abundance of information, although sifting through brochures and online resources can be daunting for the patient and their caregiver. Adhering to regulatory guidelines is an important step pharma takes to ensure that promotional medical materials contain balanced information that is accurate and relevant. 1 The marketer’s goal
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JULY 27, 2022
Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein that they hope will offer greater and broader protection against SARS-CoV-2 variants. The vaccine, codenamed BNT162b5, codes for “enhanced” prefusion spike proteins from the original wild-type strain of the virus and the Omicron variant that are designed to increase “the magnitude and breadth of the immune response.” The phase 2 trial will te
MedCity News
JULY 27, 2022
ObsEva’s uterine fibroids drug linzagolix has hit a snag at the FDA, portending a likely delayed regulatory decision. Rather than stick it out and see if its small molecule can match up against commercialized products from AbbVie and Myovant, ObsEva plans to give up rights to the drug as part of a corporate restructuring.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
PharmaVoice
JULY 27, 2022
So far, pharma has yet to provide an answer for long COVID. But award-winning lupus research by Yale professor Akiko Iwasaki help lead the way.
MedCity News
JULY 27, 2022
Mayo experts work with the companies to understand AI model requirements, check for fairness and bias in their AI models, help them understand the Food and Drug Administration clearance process and more.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 27, 2022
A panel discussion on the future of digital medicine highlighted some of the collaborations taking place between pharma companies and digital health, as well as some of the challenges facing the push towards mainstream implementation.
pharmaphorum
JULY 27, 2022
Health innovation and technology specialist Healthware Group has added another element to its business with the launch of a dedicated medical communications and education division. The new unit – dubbed Healthware MedComms – promises to take a fresh approach to medical communications that meets “the always-on, audience-centric, evidence-driven demands of today’s modern clinical environment.” It adds to Healthware’s fast-growing presence in the healthcare communications se
MedCity News
JULY 27, 2022
High levels of clinical intervention for the most at-risk patients is not needed for many of the people living in nursing homes, but a more intermediate combination of continuous monitoring, appropriate home visits, and out-patient visits would have a positive impact upon their lives, health, and the overall cost of care.
pharmaphorum
JULY 27, 2022
Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. Despite the UK’s potential as an international life sciences leader, it lags many competitors in a number of key metrics, including access to new medicines and global share of clinical trial recruitment. Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alar
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
JULY 27, 2022
Funding in FemTech startups has risen from next to nothing in 2008, to almost $2.5 billion in 2021; deals have seen the same trend, from a handful to almost 300 over the same period.
MedReps
JULY 27, 2022
In order to be a successful medical sales representative, you first need to overcome the biggest hurdle: imposter syndrome. A psychological disorder that makes people feel as though they aren’t worthy of their jobs. Imposter syndrome can really hold you back, especially when you’re trying to meet your medical sales goals. So, what is imposter syndrome, and how can you overcome it in the medical sales field?
MedCity News
JULY 27, 2022
Add Ask the Investor breakfast forum to your INVEST Digital Health agenda and gain insights from investors from DaVita Venture Group, Noro-Moseley Partners, Providence Ventures, FirstTrust Capital, Blue Cross Blue Shield Kansas, and Flare Capital Partners.
Medgadget
JULY 27, 2022
Researchers at MIT have created a microparticle vaccine that can provide booster doses automatically. The hollow microparticles resemble a coffee cup with a lid, and are made using poly(lactic-co-glycolic acid), otherwise known as PLGA. The polymer breaks down over time in the body, releasing the contents of the hollow particles. By changing the composition of the polymer and the chemical groups attached to it, the researchers can tweak the release time, allowing them to deliver an assortment of
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
MedCity News
JULY 27, 2022
Hospitals and health systems should consider implementing automated patient engagement technology that supports functions individuals value most—those that directly impact their ability to seek and receive healthcare.
PharmaVoice
JULY 27, 2022
A trickling launch for Aduhelm and a middling earnings report give Biogen executives a lot to talk about. Is there hope?
PharmExec
JULY 27, 2022
Has data science finally reached a level playing field with all of the science data being uncovered in the make, test, decide innovation cycle?
pharmaphorum
JULY 27, 2022
Pharma distributor AmerisourceBergen is working on a platform to make access to digital therapeutics (DTx) easier in the US by providing a unified system for ordering, dispensing and fulfilment. The new system – called DTx Connect – aims to help physicians order both prescription and non-prescription DTx and diagnostics through a simple interface, and monitor shipping and delivery to their patients.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
PharmaVoice
JULY 27, 2022
The 2022 president of Women in Bio is equal parts math and gender parity evangelist.
PharmaTimes
JULY 27, 2022
First carbon minimal pMDI is on track with the joint goal of benefitting patients and the planet
Pharmaceutical Technology
JULY 27, 2022
Novavax has r eceived expanded approval for provisional registration from the Australian Therapeutic Goods Agency (TGA) for its Covid-19 vaccine, Nuvaxovid (NVX-CoV2373), for use in adolescents aged 12 to 17 years. Nuvaxovid is indicated for active immunisation for the prevention of Covid-19 in individuals of this age group. It is the first protein-based vaccine to be offered in Australia for adolescents aged 12 to 17 years.
PharmaTimes
JULY 27, 2022
Predicting which women are likely to develop pre-eclampsia will help clinicians to decide on the most appropriate care
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
PharmExec
JULY 27, 2022
Using data visualizations to improve access to payers.
PM360
JULY 27, 2022
Press Release. For Immediate Release. Contact: Kayla Walsh. Awards Coordinator, PM360. 646-300-8114. kayla.walsh@pm360online.com . PM360 Now Accepting Entries for 2022 Pharma Choice Awards. Call for the Best Healthcare Creative from the Past Year. NEW YORK, NY, July 27, 2022 : The 2022 PM360 Pharma Choice Awards are officially open for entries. PM360, a leading life sciences marketing industry trade publication, established these awards 14 years ago to honor the best creative campaigns and init
PharmExec
JULY 27, 2022
Thu, Jul 28, 2022 11:00 AM EDT With no cure for IBD and other conditions, like NASH, treatments are aimed at reducing symptoms and preventing complications. Real-world data and AI applications provide a unique opportunity to better understand disease progression, treatment effectiveness, and outcomes.
Legacy MEDSearch
JULY 27, 2022
Rapid Medical , a leading developer of advanced neurovascular devices, announces FDA 510(k) clearance for TIGERTRIEVER 13 for large vessel occlusions at the 2022 Society of NeuroInterventional Surgery’s (SNIS) 19th Annual Meeting in Toronto. TIGERTRIEVER 13 is the smallest revascularization device in the world to date and is designed to remove thrombus from delicate brain blood vessels during an ischemic stroke.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Quantified
JULY 27, 2022
Sales coaching is vital for any sales organization’s success. According to Google’s Project Oxygen survey of 10,000 people, coaching is the number-one driver of performance for their organization. However, it’s often impossible for sales managers or coaches in large and dispersed sales organizations to personally evaluate, guide, and coach every rep.
Star OUTiCO
JULY 27, 2022
We spent some time chatting to Lauren about returning to work after 10 months’ maternity leave, her impressions of the industry’s development in that time, and what this means for her plans within Senior/Exec, Head Office and Marketing recruitment. Welcome back, Lauren! How is it to be back after 10 months? It’s been lovely to be back, as I love having routine and like reconnecting with candidates.
pharmaphorum
JULY 27, 2022
In its first set of financial figures since spinning off its consumer health division, GSK has reported a 19% increase in revenues, driven by burgeoning demand for its shingles vaccine Shingrix, which has helped the company to raise its full-year guidance. Total revenues came in at £6.9 billion ($8.3 billion) – ahead of forecasts – although costs associated with the separation of consumer health unit Haleon as a separately listed company contributed to a 35% decline in operating profit to £1.1 b
Pharmaceutical Technology
JULY 27, 2022
The proportion of pharmaceutical companies hiring for robotics related positions rose in June 2022 compared with the equivalent month last year, with 21.3% of the companies included in our analysis recruiting for at least one such position. This latest figure was higher than the 17.2% of companies who were hiring for robotics related jobs a year ago and an increase compared to the figure of 21.1% in May 2022.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
226 
Let's personalize your content